Efficacy and safety of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus

Medicine and Dentistry

• Glycemic Control 100%
• Maturity Onset Diabetes of the Young 100%
• Sodium Glucose Cotransporter 2 Inhibitor 100%
• Hypoglycemia 66%
• Microvascular Complication 66%
• Hyperglycemia 33%
• Cell Function 33%
• Therapeutic Agent 33%
• Glucosuria 33%
• Glucotoxicity 33%
• Oral Antidiabetic Agent 33%
• Sodium Glucose Cotransporter 33%
• Diseases 33%
• Side Effect 33%
• Pathogenesis 33%
• Insulin 33%
• Glucose 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Sodium Glucose Cotransporter 2 Inhibitor 100%
• Maturity Onset Diabetes of the Young 100%
• Hypoglycemia 66%
• Glucotoxicity 33%
• Glucosuria 33%
• Hyperglycemia 33%
• Diseases 33%
• Side Effect 33%
• Sodium Glucose Cotransporter 33%
• Pathogenesis 33%
• Glucose 33%
• Insulin 33%
• Oral Antidiabetic Agent 33%